Heo Eun-cheol, President of GC Green Cross, "Targeting Overseas Markets Through Blood Products and Vaccine Links"
2020 New Year's Address
[Asia Economy Reporter Cho Hyun-ui] Heo Eun-cheol, CEO of GC Green Cross, stated at the beginning of the new year, "We must take on a small but important mission for the healthy lives of humanity."
In his New Year's address, CEO Heo said, "We must take on a small but important mission for the healthy lives of humanity."
He also urged, "As a company with high integrity, I ask all employees to strive so that the company's success leads to the prosperity of its members and society."
Hot Picks Today
!["It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]](https://cwcontent.asiae.co.kr/asiaresize/93/2026052019230771274_1779272587.jpg)
"It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
GC Green Cross plans to accelerate its overseas market expansion this year, focusing on increased investment in research and development and its core businesses of blood products and vaccines. Last year, the company targeted the global market by applying for approval in China for the Hunter syndrome treatment 'Hunterase' and the hemophilia treatment 'GreenGene F.'
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
